DAFTAR PUSTAKA

1. Baziad A. Kontrasepsi hormonal. Jakarta: Yayasan Bina Pustaka Sarwono

Prawirohardjo;2002.h.1-50
2. Saifuddin AB. Dinamika kependudukan dan keluarga berencana. Dalam:
Wiknjosasro H, Saifuddin AB, Rachimhadhi T, penyunting. Ilmu kebidanan. Edisi
ke-3. Jakarta: Yayasan Bina Pustaka Sarwono Prawirohardjo;2006.h.889-903
3. The American College of Obstetricians and Gynaecologists Committee.
Contraceptives and congenital anomalies. Int J Gynecol Obstret. 1993; 42:316-7
4. Zierler S. Maternal drugs and congenital heart disease. J Am Col Obstet
Gynecol. 1985;65:155-63
5. The Excecutive of the Society of Obstetricians and Gynaecologists of Canada.
Principles of human teratology: drug, chemical, and infectious exposure. J Obstet
Gynecol Com. 2007;199:911-6
6. Speroff L, Fritz MA. Clinical gynecologic endocrinology and infertility. Edisi ke-7.
Philadelphia:Williams & Wilkins;2005.h.861-903
7. Affandi B. Kontrasepsi. Dalam: Wiknjosasro H, Saifuddin AB, Rachimhadhi T,
penyunting. Ilmu kebidanan. Edisi ke-2. Jakarta: Yayasan Bina Pustaka Sarwono
Prawirohardjo;2006.h.905-21
8. Albar E. Kontrasepsi. Dalam: Wiknjosasro H, Saifuddin AB, Rachimhadhi T,
penyunting. Ilmu kandungan. Edisi ke-2. Jakarta: Yayasan Bina Pustaka
Sarwono Prawirohardjo;2007.h.543-51
9. Taber LA. Biophysical mechanisms of cardiac looping. Int J Dev Biol.
2006;50:323-32
10. Creazzo TL, Godt RE, Leatherbury L, Conway SJ, Kirby ML. Role of cardiac
neural crest cells in cardiovascular development. Annu Rev Physiol.
1998;60:267-86
11. Zaffran S, Frasch M. Early signals in cardiac development. Circ Res.
2002;91:457-69
12. Waldo K, Zdanowicz M, Burch J, Kumiski D, Stadt H,Godt RE, et al. A novel role
of cardiac neural crest in heart development. J Clin Invest. 1999;103:1499-1507
13. Abdulla R, Blew GA, Holterman MJ. Cardiovascular embryology. Pediatr Cardiol.
2004;25:191-200
14. Epstein JA. Cardiac development and implications for heart disease. N Engl J
Med. 2010;17:1638-47
15. Roebiono PS, Rahaju AU, Sastroasmoro S. Embriogenesis kardiovaskular dan
sirkulasi janin. Dalam: Sastroasmoro S, Madiyono B, penyunting. Buku ajar
kardiologi anak. Jakarta: Yayasan Binarupa Aksara;1994. h.172-81
16. Srivastava D, Baldwin S. Molecular determinants of cardiac development.
Dalam: Allen HD, Gutgesell HP, Clark EB, Driscoll DJ, penyunting. Moss and
adams heart disease in infants, children, and adolescents. Edisi ke-6.
Philadelphia: Williams & Wilkins;2001.h.12-9

Universitas Sumatera Utara

17. Prasodo AM. Penyakit jantung bawaan sianotik. Dalam: Sastroasmoro S,

Madiyono B, penyunting. Buku ajar kardiologi anak. Jakarta: Yayasan Binarupa
Aksara;1994.h.234-78
18. Madiyono B, Rahayuningsih SE, Sukardi R. Penanganan penyakit jantung pada
bayi dan anak. Jakarta: Balai Penerbit FKUI; 2005.h.25-36
19. Dorfman AL, Geva T. Magnetic resonance imaging evaluation of congenital heart
disease: conotruncal anomalies. J of Cardiovasc Magn Resonance. 2006;8:64559
20. Obler D, Juraszek AL, Smoot LB, Natowitz MR. Double outlet right ventricle:
aetiologies and associations. J Med Genet. 2008;45:481-97
21. Digilio MC, Casey B, Toscano A, Calabro R, Pacileo G, Marasini M, et al.
Complete transposition of the great arteries:pattern of congenital heart disease in
familial precurrence. Circulation. 2001;104:2809-14
22. Kirby ML. Pulmonary atresia or persistent truncus arteriosus. Circ Res.
2008;103:142-8
23. Bernstein D. Congenital heart disease. Dalam: Kliegman RM, Behrman RE,
Jenson HB, Stanton BF, penyunting. Nelson textbook of pediatrics. Edisi ke-18.
Philadelphia: Saunders Elsevier;2007.h.1906-26
24. Park MK. Pediatric cardiology for practitioners. Edisi ke-4. St.Louis:Mosby
Inc;2002.h.174-202
25. Sastroasmoro S, Madiyono B. Epidemiologi dan etiologi penyakit jantung
bawaan. Dalam: Sastroasmoro S, Madiyono B, penyunting. Buku ajar kardiologi
anak. Jakarta: Yayasan Binarupa Aksara;1994.h.165-90
26. Bracken. Oral contraception and congenital malformations in offspring:a review
and meta-analysis of the prospective studies. J Obstret Gynecol. 1990;76:552-7
27. Grimes DA. Reversible contraception for women at high rik of fetal anomalies. J
Am Acad Dermatol. 1987;17:148-55
28. Pizzo TSD, Sanseverino MTV, Mengue SS. Exposure to misoprostol and
hormones during pregnancy and risk of congenital anomalies. Cad Saude
Publica. 2008;24:1447-53
29. Czeizel AE, Kodajt I. A changing pattern in the association of oral contraceptives
and
the
different
groups
of
congenital
limb
deficiencies.
Contraception.1995;51:19-24
30. Kaplan J, Hudgins L. Neonatal presentations of CHARGE Syndrome and
VATER/VACTERL Association. NeoReviews. 2008;9:299-304
31. Jenkins KJ, Correa A, Feinstein JA, Botto L, Britt AE, Daniels SR, et al.
Noninherited risk factors and congenital cardiovascular defects:current
knowledge:a scientific statement from the american heart association council on
cardiovascular disease in the young:endorsed by the American academy of
pediatrics. Circulation. 2007;115:2995-3014
32. Mone SM, Gillman MW, Miller TL, Herman EH, Lipshultz SE. Effects of
environmental exposures on the cardiovascular system:prenatal period through
adolescence. Pediatrics. 2004;113:1058-1069
33. Koren G, Pastuszak A, Ito S. Drugs in pregnancy. New England J Med.
1998;338:1128-36

Universitas Sumatera Utara

34. Bailey J, Knight A, Balcombe J. The future of teratology research is in vitro.

Biogenic Amines J. 2005;19:97-145
35. Madiyono B, Moeslichan S, Sastroasmoro S, Budiman I, Purwanto SH. Perkiraan
besar sample. Dalam: Sastroasmoro S, Ismael S, penyunting. Dasar-dasar
metodologi penelitian klinis. Jakarta: Sagung Seto; 2008. h.302-30
36. The Joint National Committee on Prevention, Detection, Evaluation, and
Treatment of High Blood Pressure. New hypertension guidelines. N Eng J Med.
2003;23:93-4
37. Perkumpulan Endokrinologi Indonesia. Konsensus pengelolaan dan pencegahan
diabetes melitus tipe 2 di Indonesia. Jakarta: Perkeni; 2011. h.20-1
38. American Psychiatric Association. Diagnostic and statistical manual of mental
disorders-text revision. Washington DC:APA:2000.h.188-98
39. Badan Pusat Statistik. Perkembangan beberapa indikator utama sosial ekonomi
Indonesia. Jakarta: Badan Pusat Statistik:2011.h.31-3
40. Hoffman JI, Kaplan S. The incidence of congenital heart disease. J Am Coll
Cardiol. 2002;39:1890-900
41. Pradat P, Francannet C, Harris JA, Robert E. The epidemiology of
cardiovascular defect, part I: a study based on data from three large registries of
congenital malformations. Pediatr Cardiol. 2003;24:195-221
42. Djer MM, Madiyono B. Tatalaksana penyakit jantung bawaan. Sari Pediatri.
2000;2:155-62
43. Harris JA, Francannet C, Pradat P, Robert E. The epidemiology of
cardiovascular defects, part II:a study based on data from three large registries
of congenital malformations. Pediatr Cardiol. 2003;24:222-35
44. Goldmuntz E, Clark BJ, Mitchell LE, Jawad AF, Cuneo BF, Reed L, et al.
Frequency of 22q11 deletions in patients with conotruncal defects. J Am Coll
Cardiol.1998;32:492-8
45. Reefhuis J, Honein MA,. Maternal age and non chromosal birth defects, Atlanta
1968-2000:teenager or thirty something, who it ask risk?. Birth defects Res A
Clin Mol Teratol. 2004;70:572-9
46. Carmichael SL, Ma C, Shaw GM. Sosioeconomic measures, orofacial clefts, and
conotruncal heart defects in California. Birth Defects Res A Clin Mol Teratol.
2009;85:850-7
47. Botto LD, Correa A, Erickson JD. Racial and temporal variation in the prevalence
of heart defects. Pediatrics. 2001;107:32-3
48. Shaw GM, Carmichael SL, Nelson V. Congenital malformations in offspring of
Vietnamese women in California, 1985-97. Teratology. 2002;65:121-4
49. Adams MM, Mulinare J, Dooley K. Risk factors for conotruncal cardiac defects in
Atlanta. J Am Coll Cardiol. 1989;14:432-42
50. Brent RL. Nongenital malformations following exposure to progestational drugs:
the last chapter of an erroneous allegation. Birth defect Res. 2005;73:906-18
51. Levy EP, Cohen A, Fraser FC. Hormone treatment during pregnancy and
congenital heart disease. Lancet. 1973;1:611-2
52. Katz Z, Lancet M, Skornik J. Teratogenicity of progestogens given during the first
trimester of pregnancy. Obstet Gynecol. 1985;65:775-81

Universitas Sumatera Utara

53. Santis MD, Cavaliere AF. Failure of emergency contraceptive levonorgestrel and
the risk of adverse effects in pregnancy and on fetal development: an
observational cohort study. Fert and Ster. 2005;84:296-9
54. Posaci C, Smitz J, Camus M, Osmanagaoglu K, Devroey P. Progesterone for the
luteal support of assisted reproductive technologies: clinical options. Human
Reproduction. 2000;15:129-48
55. Fisher B, Rose NC, Carey JC. Principles and practice of teratology for the
obstetrician. Clinical Obstetrics and Gynecology. 2008;51:106-18

Universitas Sumatera Utara